Trial Profile
To assess potential cardiac and renal toxicity of Carfilzomib combinations in Patients with Multiple Myeloma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2017
Price :
$35
*
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone; Lenalidomide; Melphalan; Prednisone
- Indications Multiple myeloma
- Focus Adverse reactions
- 23 Feb 2017 New trial record